Synopsis
Synopsis
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Centrophne
2. Dihydrochloride, Trimetazidine
3. Idaptan
4. Trimtazidine Irex
5. Trimetazidine
6. Vasartel
7. Vastarel
1. 13171-25-0
2. 1-(2,3,4-trimethoxybenzyl)piperazine Dihydrochloride
3. Trimetazidine Hydrochloride
4. Kyurinett
5. Trimetazidine Hcl
6. Trimetazidine 2hcl
7. Trimetazidine (dihydrochloride)
8. Yoshimilon
9. Vastarel F
10. 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine Dihydrochloride
11. Trimetazidine Di-hcl
12. Trimetazidine Hydrochloride [jan]
13. Trimetazidine Dihcl
14. Trimethazidine Dihydrochloride
15. Piperazine, 1-[(2,3,4-trimethoxyphenyl)methyl]-, Dihydrochloride
16. Mfcd00243086
17. 48v6723z1p
18. Nsc-759317
19. Trimetajust
20. Lubomail
21. Vastarel
22. Yosimilon
23. Piperazine, 1-((2,3,4-trimethoxyphenyl)methyl)-, Dihydrochloride
24. Dsstox_cid_25407
25. Dsstox_rid_80858
26. Dsstox_gsid_45407
27. 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine;dihydrochloride
28. Adexor
29. Piperazine, 1-((2,3,4-trimethoxyphenyl)methyl)-, Dihydrochloride (9ci)
30. Sr-01000781912
31. Ncgc00016697-01
32. Einecs 236-117-0
33. Cas-13171-25-0
34. Unii-48v6723z1p
35. S 4004
36. Kyurinett (tn)
37. Prestwick_871
38. Schembl580378
39. Chembl3561076
40. Dtxsid1045407
41. Chebi:32262
42. Piperazine, 1-(2,3,4-trimethoxybenzyl)-, Dihydrochloride
43. Hms1569n19
44. Bcp21402
45. Hy-b0968
46. Trimetazidine For System Suitability
47. Trimetazidine Hydrochloride (jp17)
48. Tox21_110568
49. S4543
50. Akos015895369
51. Tox21_110568_1
52. Ab05480
53. Ac-5896
54. Ccg-213960
55. Cs-4453
56. Ks-1125
57. Nsc 759317
58. Ncgc00016697-04
59. Trimetazidine Dihydrochloride [mi]
60. Trimetazidine Hydrochloride [mart.]
61. Trimetazidine Hydrochloride [who-dd]
62. Ft-0630397
63. T2726
64. A25088
65. D01606
66. P10117
67. 2,3,4-trimethoxybenzylpiperazine Dihydrochloride
68. 171t250
69. Sr-01000781912-3
70. Sr-01000781912-4
71. Trimetazidine Dihydrochloride [ep Monograph]
72. W-108326
73. 1-[(2,3,4-trimethoxyphenyl)methyl]piperazine Dihcl
74. Q27259190
75. F2173-1142
76. 1-(2,3,4-trimethoxybenzyl)piperazine Dihydrochloride, 97%
77. Trimetazidine Dihydrochloride 1.0 Mg/ml In Methanol (as Free Base)
78. Trimetazidine For System Suitability, European Pharmacopoeia (ep) Reference Standard
| Molecular Weight | 339.3 g/mol |
|---|---|
| Molecular Formula | C14H24Cl2N2O3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 5 |
| Exact Mass | 338.1163980 g/mol |
| Monoisotopic Mass | 338.1163980 g/mol |
| Topological Polar Surface Area | 43 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 259 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 20680
Submission : 2007-08-16
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26437
Submission : 2012-09-12
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35644
Submission : 2021-03-30
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
JPN Pharma offers excellence in API manufacturing through precision, innovation & quality, delivering solutions to the pharma industry
JPN Pharma offers excellence in API manufacturing through precision, innovation & quality, delivering solutions to the pharma industry
Certificate Number : R0-CEP 2021-092 - Rev 00
Status : Valid
Issue Date : 2023-05-10
Type : Chemical
Substance Number : 1741
Certificate Number : CEP 2008-314 - Rev 07
Status : Valid
Issue Date : 2023-10-19
Type : Chemical
Substance Number : 1741
Certificate Number : R1-CEP 2006-178 - Rev 01
Status : Valid
Issue Date : 2013-02-07
Type : Chemical
Substance Number : 1741
Certificate Number : CEP 2007-231 - Rev 04
Status : Valid
Issue Date : 2025-01-03
Type : Chemical
Substance Number : 1741
Certificate Number : R1-CEP 2015-206 - Rev 00
Status : Valid
Issue Date : 2022-10-13
Type : Chemical
Substance Number : 1741
Certificate Number : R1-CEP 2007-245 - Rev 02
Status : Valid
Issue Date : 2022-09-13
Type : Chemical
Substance Number : 1741
Certificate Number : CEP 2011-305 - Rev 05
Status : Valid
Issue Date : 2023-10-06
Type : Chemical
Substance Number : 1741
Certificate Number : R0-CEP 2021-001 - Rev 00
Status : Valid
Issue Date : 2023-02-13
Type : Chemical
Substance Number : 1741
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Certificate Number : CEP 2010-075 - Rev 02
Status : Valid
Issue Date : 2025-06-13
Type : Chemical
Substance Number : 1741
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] JDMF
Registration Number : 222MF10081
Registrant's Address : 13, rue Auguste Desgene(') tais, 76210 Bolbec, FRANCE
Initial Date of Registration : 2010-03-09
Latest Date of Registration : 2010-03-09
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
JPN Pharma offers excellence in API manufacturing through precision, innovation & quality, delivering solutions to the pharma industry
Date of Issue : 2022-03-07
Valid Till : 2024-12-16
Written Confirmation Number : WC-0336A3
Address of the Firm : Plot No. T-108/109, MIDC, Tarapur, Boisar-401 506, Taluka: Palghar, Dst: Thane, ...
Trimetazidine Dihydrochloride Ph. Eur/BP
Date of Issue : 2023-01-06
Valid Till : 2026-03-25
Written Confirmation Number : WC-0467
Address of the Firm : Unit-Il, Plot No94, SEZ, Jawaharlal Nehru Pharmacity, Lemarthi (V), Parwada (M),...
Date of Issue : 2022-07-25
Valid Till : 2025-07-02
Written Confirmation Number : WC-0124
Address of the Firm : 28A, IDA Nacharam, Hyderabad, India, Nacharam Village, Uppal Mandal, Medchal - M...
Trimetazidine Dihydrochloride BP/Ph. Eur
Date of Issue : 2022-06-03
Valid Till : 2025-07-02
Written Confirmation Number : WC-0141
Address of the Firm : D 27, MIDC, Industrial Area, Kurkumbh, Tal - Daund, Dist -Pune - 413 802, Mahara...
Trimetazidine Dihydrochloride Ph. Eur
Date of Issue : 2022-06-17
Valid Till : 2025-07-07
Written Confirmation Number : WC-0104
Address of the Firm : 125 & 126, Sipcot Industrial Complex, Hosur 635126, Tamil Nadu
Trimetazidine Hydrochloride BP
Date of Issue : 2022-06-17
Valid Till : 2025-07-07
Written Confirmation Number : WC-0104
Address of the Firm : 125 & 126, Sipcot Industrial Complex, Hosur 635126, Tamil Nadu
Trimetazidine Hydrochloride JP/EP/BP
Date of Issue : 2022-04-04
Valid Till : 2025-01-13
Written Confirmation Number : WC-0331A2
Address of the Firm : Plot No. 38, Rafaleshwar, GIDC, N. H. No 8/A, At & post Jambudia ? 363 642 Tal: ...
Trimetazidine Dihydrochloride Ph.Eur
Date of Issue : 2022-06-08
Valid Till : 2025-07-02
Written Confirmation Number : WC-0112nA2
Address of the Firm : Plot No. 69/A-2, GIDC Industrial Estate, Vapi, Dist -Valsad 396 195, Gujarat Sat...
Trimetazidine Dihydrochloride EP/BP/JP
Date of Issue : 2022-11-08
Valid Till : 2025-02-07
Written Confirmation Number : WC-0153
Address of the Firm : Plot No. L-6, MIDC Taloja, Tal.Panvel, District-Raigad-41 0208, Maharashtra, Ind...
Trimetazidine Dihydrochloride Ph.Eur/IH
Date of Issue : 2022-06-27
Valid Till : 2025-06-02
Written Confirmation Number : WC-0012
Address of the Firm : B-1/8,MIDC, Lote Parshuram, Tal., Dist. Ratnagiri, Khed - 415722, Taluka: Khed, ...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]KDMF
Registrant Name : Korea Sandoz Co., Ltd.
Registration Date : 2020-12-07
Registration Number : 20201207-209-J-583
Manufacturer Name : Anek Prayog Pvt Ltd
Manufacturer Address : 57/2, 119 MIDC Industrial Area Dhatav-Roha, District- Raigad-402 116 State: Maharasht...
Registrant Name : Korea Serviette Co., Ltd.
Registration Date : 2021-03-16
Registration Number : 20210316-209-J-878
Manufacturer Name : ORIL Industrie (Site de Bacl...
Manufacturer Address : Plaine de Baclair – 76210 BOLBEC, France
Registrant Name : Alvogen Korea Co., Ltd.
Registration Date : 2019-05-21
Registration Number : 20190521-209-J-349
Manufacturer Name : SHARON BIO-MEDICINE LTD
Manufacturer Address : Plot NO-L-6, MIDC, Taloja, Raigad, Maharashtra Raigad 410208 Maharashtra State, India
Registrant Name : Pharmapia Co., Ltd.
Registration Date : 2024-07-23
Registration Number : 20190521-209-J-349(2)
Manufacturer Name : SHARON BIO-MEDICINE LTD
Manufacturer Address : Plot NO-L-6, MIDC, Taloja, Raigad, Maharashtra Raigad 410208 Maharashtra State, India
Registrant Name : Daehan New Pharm Co., Ltd.
Registration Date : 2019-12-06
Registration Number : 20190521-209-J-349(1)
Manufacturer Name : Sharon Bio-Medicine Ltd.
Manufacturer Address : Plot NO-L-6, MIDC, Taloja, Raigad, Maharashtra Raigad 410208 Maharashtra State, India
Registrant Name : Alvogen Korea Co., Ltd.
Registration Date : 2021-06-26
Registration Number : 20210626-209-J-1039
Manufacturer Name : USV Private Limited
Manufacturer Address : B-1/8, MIDC Lote Parshuram Industrial Area, Taluka Khed, District Ratnagiri, Maharash...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
NDC Package Code : 53104-7660
Start Marketing Date : 2016-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62147-0279
Start Marketing Date : 2020-12-12
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
JPN Pharma offers excellence in API manufacturing through precision, innovation & quality, delivering solutions to the pharma industry
About the Company : JPN Pharma is a premier pharmaceutical company in India, specializing in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and drug intermediates. Headq...
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
About the Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our...
Jai Radhe Sales is your partner for all your sourcing needs.
About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
Zeon Pharma is a manufacturer and supplier of APIs & Intermediates.
About the Company : Zeon Pharma Industries India Pvt ltd is an ISO & GMP certified manufacturer of Bulk drugs & Intermediate and also supplies our associate manufacturing plant API / Semi finish form...
About the Company : Aragen is a trusted R&D and manufacturing partner to the global life sciences industry. From concept to commercial, we transform your ideas into solutions for better health. Whethe...
About the Company : Chromo Laboratories India Pvt. Ltd, is a Hyderabad based Manufacturer of Intermediates and Active Pharmaceutical Ingredients. The manufacturing facility is located at Pashamylaram...
About the Company : Cipla is a global pharmaceutical company whose goal is ensuring no patient shall be denied access to high quality & affordable medicine and support. Mission: Cipla’s mission i...
About the Company : Rakshit is an integrated API manufacturing company. Established in 2000. Today Rakshit has emerged a dependable and strong manufacturer of key APIs & intermediates for global marke...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
65
PharmaCompass offers a list of Trimetazidine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Trimetazidine Hydrochloride manufacturer or Trimetazidine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Trimetazidine Hydrochloride manufacturer or Trimetazidine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Trimetazidine Hydrochloride API Price utilized in the formulation of products. Trimetazidine Hydrochloride API Price is not always fixed or binding as the Trimetazidine Hydrochloride Price is obtained through a variety of data sources. The Trimetazidine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Idaptan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Idaptan, including repackagers and relabelers. The FDA regulates Idaptan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Idaptan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Idaptan manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Idaptan supplier is an individual or a company that provides Idaptan active pharmaceutical ingredient (API) or Idaptan finished formulations upon request. The Idaptan suppliers may include Idaptan API manufacturers, exporters, distributors and traders.
click here to find a list of Idaptan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Idaptan DMF (Drug Master File) is a document detailing the whole manufacturing process of Idaptan active pharmaceutical ingredient (API) in detail. Different forms of Idaptan DMFs exist exist since differing nations have different regulations, such as Idaptan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Idaptan DMF submitted to regulatory agencies in the US is known as a USDMF. Idaptan USDMF includes data on Idaptan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Idaptan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Idaptan suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Idaptan Drug Master File in Japan (Idaptan JDMF) empowers Idaptan API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Idaptan JDMF during the approval evaluation for pharmaceutical products. At the time of Idaptan JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Idaptan suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Idaptan Drug Master File in Korea (Idaptan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Idaptan. The MFDS reviews the Idaptan KDMF as part of the drug registration process and uses the information provided in the Idaptan KDMF to evaluate the safety and efficacy of the drug.
After submitting a Idaptan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Idaptan API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Idaptan suppliers with KDMF on PharmaCompass.
A Idaptan CEP of the European Pharmacopoeia monograph is often referred to as a Idaptan Certificate of Suitability (COS). The purpose of a Idaptan CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Idaptan EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Idaptan to their clients by showing that a Idaptan CEP has been issued for it. The manufacturer submits a Idaptan CEP (COS) as part of the market authorization procedure, and it takes on the role of a Idaptan CEP holder for the record. Additionally, the data presented in the Idaptan CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Idaptan DMF.
A Idaptan CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Idaptan CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Idaptan suppliers with CEP (COS) on PharmaCompass.
A Idaptan written confirmation (Idaptan WC) is an official document issued by a regulatory agency to a Idaptan manufacturer, verifying that the manufacturing facility of a Idaptan active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Idaptan APIs or Idaptan finished pharmaceutical products to another nation, regulatory agencies frequently require a Idaptan WC (written confirmation) as part of the regulatory process.
click here to find a list of Idaptan suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Idaptan as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Idaptan API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Idaptan as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Idaptan and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Idaptan NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Idaptan suppliers with NDC on PharmaCompass.
Idaptan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Idaptan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Idaptan GMP manufacturer or Idaptan GMP API supplier for your needs.
A Idaptan CoA (Certificate of Analysis) is a formal document that attests to Idaptan's compliance with Idaptan specifications and serves as a tool for batch-level quality control.
Idaptan CoA mostly includes findings from lab analyses of a specific batch. For each Idaptan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Idaptan may be tested according to a variety of international standards, such as European Pharmacopoeia (Idaptan EP), Idaptan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Idaptan USP).
